Procaps Group S.A. (PROC)
USD 1.01
(0.0%)
USD 1.01
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 187.24 Million USD | 20.72% |
| 2021 | 165.24 Million USD | 28.84% |
| 2020 | 128.26 Million USD | -11.59% |
| 2019 | 145.06 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | 46.13 Million USD | 7.83% |
| 2023 Q3 | 55.35 Million USD | 19.97% |
| 2023 Q1 | 42.78 Million USD | -14.5% |
| 2022 Q2 | 54.51 Million USD | 21.91% |
| 2022 Q1 | 44.71 Million USD | 13.53% |
| 2022 Q4 | 50.04 Million USD | -0.34% |
| 2022 FY | 199.47 Million USD | 20.72% |
| 2022 Q3 | 50.21 Million USD | -7.88% |
| 2021 Q4 | 39.38 Million USD | -10.19% |
| 2021 Q3 | 43.85 Million USD | 4.53% |
| 2021 Q1 | 40.05 Million USD | 29.01% |
| 2021 FY | 165.24 Million USD | 28.84% |
| 2021 Q2 | 41.95 Million USD | 4.72% |
| 2020 Q1 | 33.41 Million USD | -41.93% |
| 2020 Q4 | 31.05 Million USD | -7.6% |
| 2020 Q3 | 33.6 Million USD | 11.29% |
| 2020 Q2 | 30.19 Million USD | -9.62% |
| 2020 FY | 128.26 Million USD | -11.59% |
| 2019 FY | 145.06 Million USD | 0.0% |
| 2019 Q2 | 57.53 Million USD | 0.0% |
| 2019 Q1 | 57.53 Million USD | 0.0% |
| 2019 Q4 | 57.53 Million USD | 0.0% |
| 2019 Q3 | 57.53 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | 271.89 Million USD | 31.134% |
| Theratechnologies Inc. | 72.75 Million USD | -157.36% |
| Safety Shot Inc | 12.1 Million USD | -1446.241% |
| Cosmos Health Inc. | 26.18 Million USD | -615.2% |
| Cronos Group Inc. | 96.7 Million USD | -93.617% |
| Ironwood Pharmaceuticals, Inc. | 232.12 Million USD | 19.334% |
| Kala Pharmaceuticals, Inc. | 39.15 Million USD | -378.239% |
| Organogenesis Holdings Inc. | 314.13 Million USD | 40.393% |
| Universe Pharmaceuticals INC | 13.84 Million USD | -1252.74% |
| ProPhase Labs, Inc. | 37.85 Million USD | -394.677% |
| Sonoma Pharmaceuticals, Inc. | 9.44 Million USD | -1882.268% |
| Dynavax Technologies Corporation | 219.14 Million USD | 14.557% |
| Radius Health, Inc. | 265.92 Million USD | 29.588% |
| China SXT Pharmaceuticals, Inc. | 3.06 Million USD | -6000.799% |
| Alvotech | 285.43 Million USD | 34.401% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -1326.686% |
| Alpha Teknova, Inc. | 45.85 Million USD | -308.306% |
| Intra-Cellular Therapies, Inc. | 590 Million USD | 68.264% |
| SCYNEXIS, Inc. | 51.84 Million USD | -261.142% |
| Harrow Health, Inc. | 89.97 Million USD | -108.112% |
| Biofrontera Inc. | 39.95 Million USD | -368.593% |
| DURECT Corporation | 43.71 Million USD | -328.331% |
| Supernus Pharmaceuticals, Inc. | 529.01 Million USD | 64.605% |
| ANI Pharmaceuticals, Inc. | 195.98 Million USD | 4.459% |
| OptiNose, Inc. | 85.1 Million USD | -120.024% |
| RedHill Biopharma Ltd. | -9.56 Million USD | 2058.425% |
| Aquestive Therapeutics, Inc. | 44.85 Million USD | -317.454% |
| Cumberland Pharmaceuticals Inc. | 43.04 Million USD | -335.043% |
| SIGA Technologies, Inc. | 22.04 Million USD | -749.452% |
| Lifecore Biomedical, Inc. | 49.03 Million USD | -281.837% |
| Shineco, Inc. | 17.94 Million USD | -943.262% |
| Phibro Animal Health Corporation | 260.29 Million USD | 28.065% |
| TherapeuticsMD, Inc. | 9.82 Million USD | -1805.802% |
| Regencell Bioscience Holdings Limited | 3.99 Million USD | -4591.519% |
| Viatris Inc. | 5.96 Billion USD | 96.862% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -1326.686% |
| Rockwell Medical, Inc. | 15.37 Million USD | -1117.933% |
| Incannex Healthcare Limited | 30.05 Million USD | -523.049% |
| Aytu BioPharma, Inc. | 59.84 Million USD | -212.909% |
| Tilray Brands, Inc. | 251.35 Million USD | 25.506% |
| Collegium Pharmaceutical, Inc. | 159.2 Million USD | -17.61% |
| PetIQ, Inc. | 192.72 Million USD | 2.843% |
| Silver Spike Investment Corp. | 762.49 Thousand USD | -24456.979% |
| Neurocrine Biosciences, Inc. | 1.59 Billion USD | 88.272% |
| Journey Medical Corporation | 54.59 Million USD | -242.977% |
| Alimera Sciences, Inc. | 62.64 Million USD | -198.918% |
| Petros Pharmaceuticals, Inc. | 17.8 Million USD | -951.434% |
| Assertio Holdings, Inc. | 368.58 Million USD | 49.199% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.88 Million USD | -3081.425% |
| Embecta Corp. | 528.4 Million USD | 64.564% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -789.859% |
| Procaps Group, S.A. | 199.47 Million USD | 6.132% |
| PainReform Ltd. | 9.58 Million USD | -1853.725% |
| Avadel Pharmaceuticals plc | 164.96 Million USD | -13.505% |
| Hempacco Co., Inc. | 7.59 Million USD | -2364.902% |
| Talphera, Inc. | 11.99 Million USD | -1461.156% |
| Pacira BioSciences, Inc. | 326.37 Million USD | 42.629% |
| Alvotech | 285.43 Million USD | 34.401% |
| Lantheus Holdings, Inc. | 344.9 Million USD | 45.711% |
| Kamada Ltd. | 45.42 Million USD | -312.198% |
| Indivior PLC | 911 Million USD | 79.446% |
| Currenc Group, Inc. | 24 Million USD | -680.12% |
| Evoke Pharma, Inc. | 12.4 Million USD | -1408.867% |
| Flora Growth Corp. | 10.57 Million USD | -1669.969% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -789.859% |
| Evolus, Inc. | 189.75 Million USD | 1.325% |
| HUTCHMED (China) Limited | 436.23 Million USD | 57.077% |
| Amphastar Pharmaceuticals, Inc. | 154.13 Million USD | -21.482% |
| Akanda Corp. | 3.48 Million USD | -5275.185% |